Introduction
Epilepsy is a neuronal disorder that affects people worldwide, which may reflect the imbalance in the excitatory and inhibitory activity of neurons. 1, 2 Recently, gap junctions (GJs) were proposed to participate in seizure activity on the basis of electrophysiological, pharmacological and molecular evidence obtained in vitro [3] [4] [5] [6] [7] and in vivo. [8] [9] [10] Indeed, GJ blockers such as carbenoxolone and quinine, as well as openers such as trimethylamine (TMA), display antiepileptiform and proepileptiform effects, respectively. 4, [8] [9] [10] [11] [12] [13] [14] 4-Aminopyridine (4-AP) is an agent that promotes convulsions by blocking K + channels, thereby prolonging action potentials in neurons and facilitating the non-specific release of neurotransmitters. Moreover, this agent may also induce synaptic glutamate release in some regions, 2, 15 and it was suggested that such as increase in extracellular glutamate may provoke the overactivation of postsynaptic excitatory glutamate receptors, thereby inducing seizures and convulsive behavior. However, low concentrations of 4-AP also produce epileptiform activity without affecting glutamate levels, 16, 17 which led us to think of alternative mechanisms to provoke seizures in the 4-AP model, such as through GJs. Some in vivo studies have examined the influence of agents that alter GJ activity in the 4-AP model, producing both antiepileptic and proepileptic effects. However, such studies have concentrated on neocortical structures and they have been performed on anesthetized animals. 8, 9 We previously found that carbenoxolone, a blocking agent that non-specifically binds to and closes GJ channels, decreases the amplitude and frequency of epileptiform activity, as well as dampening seizure behavior induced by 4-AP in the rat entorhinal cortex (EC) and hippocampus. 10 These limbic structures are important sites for seizure generation, and GJs in CA1 pyramidal neurons (non-principal neurons, such as hippocampal interneurons) may play an important role in the hypersynchronization of this epileptiform activity. 6, 10, 18 Accordingly, we set out to further examine this hypothesis by analyzing the effects of quinine (a specific Cx36 GJ blocker) and TMA (a GJ opener that causes intracellular alkalinization) in the EC and the CA1 hippocampal region of 4-AP treated rats, and to determine whether TMA exerts a synergistic effect in this model. We examined the effects of these drugs on specific EEG parameters, 4-AP Connexin 36 Entorhinal cortex Quinine Seizures Trimethylamine
A B S T R A C T
In vivo and in vitro evidence from animals suggesting that gap junctions (GJs) play a role in the spreading of epileptiform activity. We have examined the influence of the gap junction opener trimethylamine (TMA) and the connexin 36 (Cx36) gap junctional blocker, quinine, on epileptiform activity induced by 4-aminopyridine (4-AP) in the rat entorhinal cortex (EC) and the CA1 hippocampal region. A cannula and surface electrodes were implanted into the brain to administer drugs and to monitor electrical activity. Injection of 4-AP (10 nmol) produced epileptiform discharge trains of high amplitude and frequency associated with seizure behavior rated between 0 and 3 in the Racine scale. In the presence of TMA (500 nmol), 4-AP produced distinct epileptiform patterns with continuous, long epileptiform discharges of high amplitude and frequency associated with seizure behavior of 0, 1, 3 and 5 during the first 30 min post-drug administration that diminished after 90 min. Quinine injection (35 pmol) into the EC of seizing animals decreased the amplitude and frequency of the discharge trains in the EC and CA1 regions, which were completely blocked after 34 min. Indeed, the seizure behavior of the animals was completely blocked in five of the six rats 53.2 s after quinine administration. We suggest that the intensity of the proepileptic effect of TMA on epileptiform activity depends on the time and route of drug administration, and that neural Cx36-dependent GJs are important structures in the generation of epileptiform activity, as well as in the seizure behavior induced by 4-AP.
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including amplitude, frequency and propagation of epileptiform activity, as well as their influence on seizure behavior of 4-AP treated rats. The results obtained provide further insight into the participation of GJs in epileptiform activity.
Materials and methods

Animals
Twenty-six adult male Wistar rats (250-350 g) were used in these experiments, in a manner designed to minimize the number of animals. Animals were housed in a temperature regulated room with free access to food and water, and on a 12-h day/12-h night cycle. This study conformed to the Rules for Health Research Matters (Mexico) and it was approved by the local Animal Care Committee.
Surgery
The animals were first anesthetized with isofluorane in 100% O 2 and secured in a Stoelting stereotaxic frame with the incisor bar positioned at À3.3 mm. A stainless steel guide cannula (0.5 mm internal diameter) was implanted into each rat through a hole drilled in the skull, positioned at the stereotaxic coordinates of the right EC (EC: AP = À8 mm, L = 4.6 mm and V = 4 mm from the bregma). A cannula was used to insert an injection needle (V = 5 mm) that also served as a recording electrode and, it was insulated by varnishing the whole surface but the final 1 mm portion from its tip. In addition, three stainless steel screws were driven into the bone, two above the bregma and one above the cerebellum, which served as indifferent and ground electrodes, respectively. One surface electrode, with the same characteristics as the electrodes mentioned above, was implanted into the skull above the right CA1 region of the hippocampus (AP = À5.6 mm and L = 5.0 mm from the bregma) and it was also used as a recording electrode. The guide cannula and surface electrode wires were attached to a socket connector and fixed to the skull with acrylic dental cement.
Animal groups and drug administration
After surgery, the animals were allowed to recover for 24 h and they were divided into three control and two experimental groups as follows: (a) a group that was administered a dose of 10 nmol 4-AP (n = 6); (b) a group of animals that received two injections of NaCl (0.9%) and TMA (a 500 nmol dose) at different times, 30 min and 220 min after the EEG recording was initiated (n = 3); (c) a group of rats that received a dose of 35 pmol quinine injection (n = 5); (d) an experimental group that received an injection of 4-AP and TMA (n = 6); and (e) an experimental group of animals that received 4-AP and an injection of quinine 30 min after the epileptiform pattern was established (n = 6).
All the drugs were obtained from Sigma (St. Louis, MO, USA) and they were administered into the EC. The 4-AP was injected at the appropriate concentration of NaCl to maintain iso-osmolarity. All drugs were injected at a flow rate of 0.2 ml/min for 5 min (final volume 1 ml) using a microsyringe mounted on a BAS microinjection pump and they were all diluted in saline solution.
EEG recording
The rats were placed in a container unit and connected to a cable that was fixed to a balanced arm. The EEG was recorded using a Grass polygraph with a low-frequency filter at 1 Hz and a highfrequency filter at 300 Hz, sampled at 100 Hz/channel (two channels). The data were stored on a computer hard disk and analyzed with PolyView 2.1 software. After a 30 min period of recording basal activity, the first group of animals received a 4-AP injection (10 nmol) and they were then observed continuously for approximately 120 min during EEG recordings. The other control and experimental groups were recorded for 30 min as the basal period before the drugs were administered, and for 90 min after treatment. These animals were also observed continuously. The basal electrical activity of all groups of animals was analyzed, averaging the amplitude and frequency during a period of 3 min along the recording.
To understand the effects of TMA and quinine on epileptiform activity in this seizure model, the data were analyzed by measuring the amplitude of single epileptiform discharges during a 1 min period at different times after drug administration. The frequency of the EEG epileptiform activity (the number of single epileptiform discharges during a one second seizure period) was averaged manually for 1 min according to the different times studied. Propagation of this epileptiform activity to the CA1 region through the hippocampus-entorhinal cortex circuit was also analyzed.
Behavioral study
In general, the behavior of all the rats in the control and experimental groups was studied by continuous observation before, during and after drug administration. The Racine scale was used to assess the animals 19 with minor modifications to adapt it to this seizure model as follows 10 : 0, behavioral arrest (motionless), hair raising, excitement and rapid breathing; 1, movement of the mouth lips and tongue, vibrissae movement and salivation; 2, head clonus and eye clonus; 3, forelimb clonus, ''wet dog shakes''; 4, clonic rearing; 5, clonic rearing with loss of postural control and uncontrollable jumping.
Histological evaluation
The location of the guide cannula was verified after each experiment. For this purpose, the animals were anesthetized with sodium pentobarbital, transcardially perfused with 100 ml of normal saline (0.9%) in 0.12 M buffer/CaCl 2 , followed by 300 ml of 4% paraformaldehyde in 0.12 M buffer/CaCl 2 [pH 7.3]. The animal's brain was then removed, and coronal sections (50 mm thick) were obtained and stained with cresyl violet. Animals in which the cannula did not reach the exact position required were not included in the study.
Data analysis
The results are shown as the mean (AESEM), and the comparisons between the control and experimental groups were performed using the Mtab13 statistical software package applying an one-way analysis of variance (ANOVA) with a Tukey-Kramer post hoc test. Statistical significance was considered at p < 0.05.
Results
The basal EEG activity of the control animals that received NaCl, 4-AP, TMA and quinine was generally characterized by physiological slow waves of low amplitude and frequency, similar to the basal EEG activity in the experimental groups (Figs. 1A, B and C, and 4C). The group of rats that received an injection of 4-AP into the EC developed epileptiform activity that was initially characterized by hypersynchronous activity followed by trains of poly-spikes. The low amplitude and frequency spike-wave complexes observed in these animals increased during the experiment, and almost immediately propagated to the CA1 region (latency to the first epileptiform discharge EC 21 AE 8.02 s, CA1 75.7 AE 27.3 s: Fig. 1B) .
Effect of trimethylamine on seizure activity in the EC and CA1 region of the hippocampus
No significant changes in EEG activity were observed during the experiment in the control groups that received NaCl and TMA ( Fig. 1A and C) . However, when 4-AP was co-injected with TMA into the EC, epileptiform discharges of high amplitude and frequency were observed in the EC and CA1 region for up to 90 min (Fig. 1D ). There were no significant differences in the epileptiform activity between this experimental group of animals and the control group that received 4-AP alone, except for a significant decrease in the frequency of epileptiform discharges in the CA1 region 90 min after co-injection of 4-AP/TMA (Fig. 2) . By contrast, significant differences in amplitude and frequency were observed in the EC and CA1 regions of these experimental animals with respect to the electrical activity in the saline and TMA control rats (Fig. 2) . Moreover, there was a tendency toward a decrease in the amplitude of epileptiform activity in both the EC and CA1 regions 90 min after 4-AP/TMA co-injection in these experimental animals (Fig. 2) . Furthermore, 4-AP/TMA co-injection modified the typical epileptiform pattern observed after 4-AP administration in the EC region. Thus, rather than a train of epileptiform discharges, continuous extended epileptiform activity (status epilepticus) was observed in both regions studied (Fig. 3A and B) . In four of the six rats, these epileptiform discharges were observed in the EC region but not in the CA1 region of hippocampus (Fig. 3C). 3.2. Effect of quinine on seizure activity in the EC and CA1 region of the hippocampus No significant differences in electrical activity were observed in the saline and quinine control groups (Fig. 4A and C) . When 4-AP was administered to the experimental group, a classical epileptiform pattern was observed in both the EC and CA1 regions, although there was a significant reduction in the frequency of the epileptiform discharges in the CA1 of these experimental animals when compared with 4-AP control group (Figs. 4 and 5) . Injection of quinine 30 min after 4-AP in these seizing animals, decreased the amplitude and frequency of the epileptiform discharges in the EC and CA1 regions, and such discharges were completely blocked 34 AE 4.3 min after quinine administration, with no further recurrence for the duration of the recording (90 min, Fig. 5 ). This antiepileptiform effect of quinine was significant, both immediately following the injection as well as 90 min after quinine administration, in the regions of the seizing animals studied (Fig. 5) .
Effect of trimethylamine and quinine on seizure behavior
The 4-AP treated rats were attributed a rating of 0, 1 and 3 in the modified Racine scale during the experiment (120 min). Two of six rats also received a score of 2 in the scale (Table 1A) . According to this scale, there was no seizure behavior in the rest of the control animals, and they only presented sporadic tidying and scratching activity before and after drug administration.
Co-injection of 4-AP/TMA produced a rating of 0, 1, 3 and 5 during the first 30 min after administration, although a score of 5 was observed in two of the six rats. The animals were still rated as 0 and 1 on this scale at the end of the experiment, although 120 min after co-injection of the drugs, one rat was still attributed a score of 3 (Table 1B) .
Finally, quinine injection in 4-AP treated rats decreased seizure behavior, which was completely blocked in five of six rats at 53.2 AE 10.5 s. Indeed, only one animal remained with a rating of 1 in the modified scale at the end of the experiment (90 min post-quinine injection), although the scores of this rat had tended to decrease from 3 to 1 over the last 60 min after the quinine injection (Table 1C) .
Discussion
In this work, 4-AP (10 nmol) administration to the EC produced epileptiform activity characterized by high amplitude and frequency discharge trains. This activity propagated to the CA1 region almost simultaneously and it was correlated with seizure behavior rated as 1, 2 and 3 according to the modified Racine scale. We found certain variation in the basal electrical activity, as well in the epileptiform activity in different control and experimental groups, which is probably due to the individual variability between subjects and the fact that the experiments were carried out at different times according to the availability of the animals. There is evidence that 4-AP administration to rats preferably increases extracellular glutamate levels in the hippocampus, 2 suggesting that this drug might induce seizures through the hyperactivation of postsynaptic glutamate receptors. 1, 15 However, low concentrations of 4-AP can produce epileptiform activity without affecting glutamate levels. 16, 17 Hence, 4-AP may generate seizures by an alternative mechanism unrelated to chemical synapses, although we cannot rule out the participation of neurotransmitter systems other than glutamate. Many studies have found that GJs between cells in the CNS participate in epileptiform activity in several in vitro models, 4, 18 some GJ blockers and openers demonstrating antiepileptic and proepileptic activity, respectively. 4, 7, 11, 13, 18 Indeed, carbenoxolone and quinine are non-specific and specific GJ blockers that display antiepileptic activity, 9,10 while the GJ opener TMA exerts a proepileptic effect in some in vivo studies. 8, 20 In this study, 4-AP/TMA co-injection into the EC region of vigilant animals produced epileptiform discharges of high amplitude and frequency that persisted throughout the experiment (90 min), and that were similar to those obtained in animals that received 4-AP alone. However, in four of six rats this epileptiform activity was only observed in the EC region and the frequency of epileptiform activity decreased throughout the experiment in both regions studied, as did the seizure behavior score. During the experiment the classical pattern of epileptiform activity found in our previous study, 10 involving epileptiform discharge trains of high amplitude and frequency, changed to a pattern of continuous epileptiform discharges similar to status epilepticus. Throughout the first 30 min after of 4-AP and TMA administration, this epileptiform activity was associated with seizure behavior that was classified with a score of 0, 1, 3 and 5 according to the modified Racine scale, although a score of 5 was only observed in two of the six rats. These data differ from earlier studies, 8, 9 where TMA increased the duration and amplitude of seizures induced by 4-AP in the neocortex of anesthetized rats, facilitating seizure propagation. In these earlier studies, the drugs like 4-AP were administered via filters placed directly onto the neocortex and these filters remained in place throughout the experiment (continued drug delivery), which might have facilitated the proepileptic effect of this drug. Using this protocol of drug administration it is not possible to precisely control the exact dose of the drug administered. By contrast, the administration of 4-AP and TMA into the EC was carefully regulated here (flow rate: 0.2 ml/min for 5 min) and final doses of 10 and 500 nmol, respectively, were applied. Therefore, we propose that local injection of a specific dose of 4-AP and TMA, coupled with the short administration times used here might explain the differences in the data found between these studies. Although TMA reverts the anticonvulsant properties of quinine in the pentylenetetrazole model, 20 no changes in the latency to the first generalized tonic-clonic seizure were found when TMA was administrated at different doses 40 min before pentylenetetrazole. These latter results are in agreement with our data, since we did not find any pro-convulsive synergistic effect of TMA, even when 4-AP and TMA were delivered together. Nevertheless, we did observe an interesting change since the classic pattern of epileptiform activity induced by 4-AP was modified to continuous epileptiform discharges, while the convulsive behavior of some of the animals in this group shifted from a rating of 3-5 in the modified Racine scale, only during the first 30 min after co-injection of 4-AP and TMA. In the light of these results, we highlight the importance of considering that the effects of TMA in the 4-AP model depend on the dose and method of drug administration. We cannot rule out the fact that other nonsynaptic mechanisms also play a role in 4-AP induced seizures, such as electric field effects or ionic interactions, 3 or other neurotransmitter systems not related to glutamate. Quinine specifically blocks Cx36, yet at low concentrations quinine can also block ATP-sensitive and voltage-dependent K + channels, as well as nicotinic and cholinergic receptors, and at high concentrations it affects Cx45 GJs and IP 3 -induced Ca 2+ release. 21 Nevertheless, in vitro studies demonstrated that quinine did not affect basal electric activity and neuronal excitability. 24, 25 A specific dose of quinine that selectively blocks Cx36 proteins localized in the GJs of neurons was used here, 21 and this administration of quinine produced a decrease in the amplitude and frequency of the epileptiform discharge trains induced by 4-AP. In addition, it completely blocked seizure activity in both the EC and CA1 regions. Furthermore, quinine administration blocked animal seizure since only one rat remained with a score of 1 in the modified Racine scale. These results are in agreement with other studies where quinine application decreased the convulsive activity induced by 4-AP, penicillin or pentylenetetrazole in animals. 9, 14, 20 Previously, 8 quinine has been administered to the neocortex of anesthetized animals at a concentration of 35 mM in a continous release paradigm, while in other studies, 14 the anticonvulsive effect of quinine was dose-dependent when applied to the frontal and parietal cortex (from 200 to 400 or 1000 nmol). Here, we observed an anticonvulsive effect of quinine when injected during a short time period into the EC, even at the lowest doses tested (35 pmol), as well as in the epileptiform activity propagated to the CA1. This result led us to contemplate the participation of GJs in neurons during epileptiform activity, as in the motor activity behind the effects of 4-AP. Table 1 Seizure behavior of three groups of rats that received different drug injections in the EC region: (A) rats injected with 4-AP (10 nmol, n = 6); (B) 4-AP/TMA co-injected animals (10 and 500 nmol, respectively; n = 6); (C) 4-AP treated rats injected with quinine 30 min after epileptiform pattern was established (35 pmol, n = 6). The symbol * represents the time period when no more changes in seizure behavior were observed, according the modified Racine scale. It should be highlighted that this is the first study in the 4-AP seizure model where the effects of TMA and quinine administration on EEG activity in the EC have been assessed in vigilant animals. Previous studies have analyzed the effects of these drugs in vitro 4, 7, 11, 13, 18 and the available in vivo studies have been carried out on anesthetized animals or alternatively, the drugs have been administered to other brain regions, such as the cortex. 8, 9, 12, 14 GJ communication between interneurons in the hippocampus is thought to influence their behavior. 3, 6, 22 Moreover, 4-AP induces synchronized discharges that can be blocked by GABA A receptor antagonists, 17, 23 which might be related to the hypersynchronization of GABAergic interneurons during epileptiform activity. These data support the hypothesis that the contribution of GJs might favor the hypersynchronization of epileptiform activity induced by 4-AP between different types of interneurons in the EC and CA1 regions studied here. We cannot rule out the influence of the coupling of interneurons through GJs and glutamate transmission in this seizure model, which might participate in the generation and maintenance of epileptiform activity at high 4-AP concentrations. Indeed, it is possible that GJs located in neurons from these regions may contribute to seizures after the injection of low 4-AP concentrations. Recent experimental evidence indicates that glutamate may be released through hemichannels or connexons (components of GJs) and that this release mechanism is functional in astrocytes within the nervous system. [26] [27] [28] We cannot ignore this possibility since a similar mechanism of glutamate release at low 4-AP concentrations might produce seizures in vivo. Nevertheless, the levels ofglutamate released by this mechanism may not be sufficient to be detected by classical techniques. We are currently working with a novel device that permits glutamate to be measured in small fractions with a better time resolution in order to study this hypothesis. 29 Finally, the present results sustain the belief that the effect of TMA on epileptiform activity, as well as on seizure behavior, depends on the duration and route of drug administration. We conclude that coupling GABAergic interneurons and principal neurons by GJs, both in the EC and CA1 hippocampal regions could synchronize epileptiform activity at the site of generation, as well as in other propagated brain areas. GJs are also important structures in the generation of seizure behavior induced by 4-AP in the regions studied. Given that the low dose of quinine does not alter EEG activity or the behavior of rats, we suggest that the use of this specific GJ blocker may pave the way for new strategies to treat seizures, as observed in this model of experimental epilepsy.
